Anthem, Inc. completed the acquisition of myNEXUS, Inc. from an investor group led by WindRose Health Investors, LLC.
April 27, 2021
Share
Anthem, Inc. (NYSE:ANTM) entered into an agreement to acquire myNEXUS, Inc. from an investor group led by WindRose Health Investors, LLC on March 24, 2021. Upon closing, myNEXUS will operate as a wholly-owned subsidiary of Anthem and will join Anthem's Diversified Business Group. The acquisition is subject to customary closing conditions including regulatory approvals and is expected to close in the second quarter of 2021. As per filing of April 24, 2021, the transaction is expected to close by the end of the second quarter of 2021. Dan Dufner, Michael Deyong and Henrik Patel of White & Case LLP and Faegre Drinker Biddle & Reath LLP acted as legal advisor to Anthem. Alexander B. Johnson of Latham & Watkins LLP and Waller Lansden Dortch & Davis, LLP are acting as legal advisors for myNEXUS. Morgan Stanley and UBS Securities LLC acted as financial advisor to myNEXUS, Inc. Oppenheimer & Co. Inc. acted as financial advisor to myNEXUS, Inc.
Anthem, Inc. (NYSE:ANTM) completed the acquisition of myNEXUS, Inc. from an investor group led by WindRose Health Investors, LLC on April 28, 2021.
Elevance Health, Inc. is the American leading of health insurance. The group provides a broad range of medical and specialty products and services (life and disability insurance, medication, dental, vision insurance system and behavioral care insurance system, long-term health care insurance, medical expenses management, etc.).
Elevance Health, Inc. is an independent licensee of the Blue Cross and Blue Shield Association, an independent association providing health insurance system.
At the end of 2023, the group had nearly 47 million medical members.
ELEVANCE HEALTH, INC. 
